Enterprise Financial Services Corp (EFSC)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-600
Closed -$28K – 468
2021
Q3
$28K Hold
600
– – ﹤0.01% 314
2021
Q2
$31K Hold
600
– – 0.01% 494
2021
Q1
$30K Hold
600
– – 0.01% 511
2020
Q4
$31K Hold
600
– – 0.01% 479
2020
Q3
$26K Hold
600
– – 0.01% 504
2020
Q2
$26K Hold
600
– – 0.01% 499
2020
Q1
$22K Hold
600
– – 0.01% 491
2019
Q4
$27K Hold
600
– – 0.01% 528
2019
Q3
$21K Hold
600
– – ﹤0.01% 554
2019
Q2
$23K Hold
600
– – 0.01% 556
2019
Q1
$25K Buy
+600
New +$24.4K 0.01% 533

Other funds holding XPH

Enterprise Financial Services Corp (EFSC)'s XPH Position: Q4 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2021, closing a stake of 600 shares — an estimated $28K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in XPH in Q1 2019 and held it in 11 quarters. The position peaked at $31K in Q2 2021. 77 funds tracked by Wall St. Rank hold XPH as of Q4 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 600 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2021, an estimated $28K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2019 and held it in 11 quarters.
  • Enterprise Financial Services Corp (EFSC)'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $31K in Q2 2021.
  • 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2021, filed 14 Feb 2022.